Braeburn Pharmaceuticals

Braeburn Pharmaceuticals

  • Founded: 2012
  • Location: Plymouth Meeting, PA
  • Employee range: 11 - 50
  • Clinical stage: COM
  • Therapy area: Opioid use disorder
  • Drug types: ABU
  • Lead product: Brixadi
  • Product link: https://braeburnrx.com/pipeline/
  • Funding: $100M Jan 2018


braeburnrx.com

linkedin.com

job board


Short description:

Out licensing

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Braeburn is developing drugs to fight against opioid addiction. Opioid overdose and misuse are a significant public health crisis in the US today affecting 2 million people. To treat opioid addiction, Braeburn is developing a FluidCrystal® injection depot technology, a next generation delivery system that includes a lipid-based liquid with a dissolved active ingredient. Braeburn is adapting this technology to deliver buprenorphine, a medication that normalizes brain chemistry and blocks the euphoric effects of opioids relieving physiological cravings without negative effects. The extended-release injected therapy of buprenorphine for weekly and monthly subcutaneous injections for moderate to severe opioid use disorder was recently accepted by the FDA.

Jobs:

Braeburn Pharmaceuticals
Associate Director of Training
Hybrid/ Remote|11 days ago
Apply
Braeburn Pharmaceuticals
Key Account Manager - Los Angeles, CA
Remote - Los Angeles, CA|19 days ago
Braeburn Pharmaceuticals
Key Account Manager - Chicago, IL South
Remote - Chicago, IL South|26 days ago
Braeburn Pharmaceuticals
Medical Science Liaison - Southeast
Remote|33 days ago
Braeburn Pharmaceuticals
Manager, Sales Operations
Remote - Plymouth Meeting, PA|39 days ago
Braeburn Pharmaceuticals
Pricing and Contracting Manager
Plymouth Meeting, PA|80 days ago
Braeburn Pharmaceuticals
Director of Trade
Plymouth Meeting, PA|80 days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com